Page last updated: 2024-09-03

valdecoxib and Dyspepsia

valdecoxib has been researched along with Dyspepsia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eisen, GM; Goldstein, JL; Hanna, DB; Rublee, DA1
Goldstein, JL; Mayne, TJ; Rabeneck, L; Rublee, DA; Vu, A1
Bevirt, T; Makarowski, W; Recker, DP; Zhao, WW1

Reviews

1 review(s) available for valdecoxib and Dyspepsia

ArticleYear
Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
    Alimentary pharmacology & therapeutics, 2005, Mar-01, Volume: 21, Issue:5

    Topics: Abdominal Pain; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; Dyspepsia; Female; Humans; Isoxazoles; Male; Middle Aged; Nausea; Osteoarthritis; Randomized Controlled Trials as Topic; Sulfonamides

2005

Trials

2 trial(s) available for valdecoxib and Dyspepsia

ArticleYear
Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    The American journal of gastroenterology, 2005, Volume: 100, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Dyspepsia; Female; Humans; Ibuprofen; Isoxazoles; Male; Middle Aged; Naproxen; Osteoarthritis; Pain Measurement; Patient Satisfaction; Placebos; Quality of Life; Sulfonamides; Treatment Outcome; Upper Gastrointestinal Tract

2005
Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
    Osteoarthritis and cartilage, 2002, Volume: 10, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Constipation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Administration Schedule; Dyspepsia; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis, Hip; Prostaglandin-Endoperoxide Synthases; Sulfonamides

2002